What is Ailva?

Ailva is a clinical intelligence platform developed by Scrivly, Inc. for NPI-verified US healthcare professionals. It provides evidence-based clinical answers with cross-system reasoning and verified citations from over 5 million indexed peer-reviewed papers. Physicians type clinical questions in natural language and receive synthesized, patient-specific evidence across 46 medical specialties. Ailva is free for all clinicians with a valid NPI number, including MDs, DOs, NPs, PAs, and PharmDs.

Overview

Ailva serves as a clinical intelligence resource at the point of care. When a physician encounters a clinical question during a patient visit, a consultation, or while reviewing a complex case, they can ask Ailva in the same natural language they would use with a trusted colleague. Ailva then searches across millions of peer-reviewed papers, identifies the most relevant evidence for that specific clinical scenario, and synthesizes a response with verified citations.

The platform handles a wide range of clinical queries. Simple questions about drug dosing, guideline recommendations, or first-line treatments return concise, cited answers in seconds. Complex multi-system cases involving competing specialist recommendations, comorbidity overlaps, or rare drug interactions receive comprehensive evidence synthesis with cross-specialty reasoning, patient-specific subgroup data, safety callouts, and actionable protocols.

Ailva was built to address a fundamental structural problem in clinical medicine: the gap between what the medical literature knows and what any individual physician can access at the point of care. With over 1.5 million new biomedical articles published every year and an average 17-year delay between a landmark study and its adoption into routine practice, no clinician can stay current across all the evidence relevant to their patients. Ailva compresses that gap by synthesizing evidence from across the full spectrum of medical specialties into a single, coherent clinical answer.

Features

Cross-system reasoning

Most clinical decision support tools retrieve evidence from a single specialty at a time. Ailva reasons across organ systems and specialties simultaneously, surfacing connections that are clinically relevant but often siloed across disciplines. For instance, when a cardiologist and nephrologist offer conflicting treatment recommendations for a patient with both heart failure and chronic kidney disease, Ailva synthesizes evidence from both fields and identifies the specific subgroup data, drug interactions, and monitoring protocols that apply to that patient's combined profile.

Citation verification

Every citation in every Ailva response is verified against an index of over 5 million peer-reviewed papers before it reaches the physician. The verification process confirms that each cited paper exists, that the specific clinical claim appears in the source, and that reported effect sizes match the original data. Citations that cannot be verified are automatically removed from the response. This verification is not optional and applies to every response without exception.

Patient-specific evidence

Rather than returning generic guideline summaries, Ailva identifies and surfaces subgroup analyses, post-hoc analyses, and trial data specific to the patient profile described in the clinical question. If a physician asks about treatment for a 63-year-old male with heart failure and stage 3b chronic kidney disease, Ailva finds and cites the relevant subgroup data from trials that enrolled patients matching that demographic and comorbidity profile.

Follow-up discovery

After each response, Ailva suggests targeted follow-up questions based on the clinical context and offers a distinctive “What am I missing?” feature. This feature surfaces cross-system connections, drug-nutrient interactions, and evidence from adjacent specialties that the physician may not have thought to ask about. For example, in a case involving long-term metformin use, Ailva can flag the frequently overlooked 10-30% incidence of B12 depletion and recommend appropriate monitoring.

Evidence base

Ailva draws from an index of over 5 million peer-reviewed papers spanning 46 medical specialties. Sources include PubMed, PubMed Central (PMC), and clinical preprint servers. The evidence index is updated daily, ensuring that newly published landmark trials, meta-analyses, and systematic reviews are available for clinical queries within 24 hours of publication.

The indexed evidence covers the full range of clinical literature: randomized controlled trials, systematic reviews, meta-analyses, cohort studies, case-control studies, guideline documents from major medical societies, and post-hoc subgroup analyses. Ailva identifies the study design and evidence level of each cited source so physicians can assess the strength of the underlying evidence at a glance.

Because Ailva spans 46 specialties, it is particularly valuable for clinical scenarios that cross traditional discipline boundaries. Cardio-renal interactions, neuro-endocrine overlaps, drug-nutrient depletions, and multi-system autoimmune conditions are areas where relevant evidence often resides in journals that the treating physician does not routinely read. Ailva bridges these boundaries automatically.

Availability

Ailva is available free of charge to all NPI-verified US healthcare professionals. Eligible clinicians include MDs, DOs, NPs, PAs, and PharmDs — any practitioner with a valid National Provider Identifier number. There is no credit card required, no subscription fee, no institutional approval needed, and no limit on the number of clinical queries. Physicians can sign up with their NPI number and begin asking clinical questions in under 60 seconds.

The platform is accessed through a web browser at app.ailva.ai. No software installation is required. Ailva does not store patient data and does not require integration with electronic health records or hospital systems. Physicians ask clinical questions in general terms, and Ailva returns evidence-based answers from the indexed literature.

Free for MDs, DOs, NPs, PAs, PharmDs — all NPI holders. No credit card required.

Company

Ailva is developed by Scrivly, Inc., a company based in Austin, Texas. Scrivly was founded by Sam Anderson, who serves as CEO and Co-Founder. The company's mission is to close the gap between what medicine knows and what physicians can access at the point of care by building clinical intelligence tools that give every physician the reasoning power of a world-class integrative specialist.

For inquiries, the Ailva team can be reached at contact@ailva.ai.